(1S,3R)-N-(3-Hydroxy-1-hydroxymethyl-3-phenylprop-1-yl)dodecan-amide

ID: ALA3401791

Chembl Id: CHEMBL3401791

PubChem CID: 11079004

Max Phase: Preclinical

Molecular Formula: C22H37NO3

Molecular Weight: 363.54

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCC(=O)N[C@H](CO)C[C@@H](O)c1ccccc1

Standard InChI:  InChI=1S/C22H37NO3/c1-2-3-4-5-6-7-8-9-13-16-22(26)23-20(18-24)17-21(25)19-14-11-10-12-15-19/h10-12,14-15,20-21,24-25H,2-9,13,16-18H2,1H3,(H,23,26)/t20-,21+/m0/s1

Standard InChI Key:  YCAKBKAOFSILDC-LEWJYISDSA-N

Associated Targets(Human)

STARD7 Tbio StAR-related lipid transfer protein 7, mitochondrial (7 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CERT1 Tbio Collagen type IV alpha-3-binding protein (18 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 363.54Molecular Weight (Monoisotopic): 363.2773AlogP: 4.51#Rotatable Bonds: 15
Polar Surface Area: 69.56Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.42CX LogD: 4.42
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.40Np Likeness Score: 0.05

References

1. Santos C, Fleury L, Rodriguez F, Markus J, Berkeš D, Daïch A, Ausseil F, Baudoin-Dehoux C, Ballereau S, Génisson Y..  (2015)  The CERT antagonist HPA-12: first practical synthesis and individual binding evaluation of the four stereoisomers.,  23  (9): [PMID:25818765] [10.1016/j.bmc.2015.03.019]

Source